spacer
home > pmps > summer 2007 > finding your voice
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Finding Your Voice

Greg Tanner of Vocollect Europe discusses the possibility of gaining better visibility in the pharmaceutical pipeline via voice systems

In recent years, the pharmaceutical industry has undergone vast transformation. Manufacturing innovation has led to a dramatic increase in the number and complexity of products. The regulatory landscape has changed beyond recognition; regulatory bodies try to retain control of the growing threat of bioterrorism and drug counterfeiting, and prices have been driven down by competition from generic drug sales and the increased negotiating power of managed-care providers.

With companies under more pressure than ever before to manage regulatory compliance, increase productivity and drive profit, the pharmaceutical supply chain has inevitably come under the spotlight. Recent studies (Streamlining Pharmaceutical Manufacturing and Distribution While Preparing for a More Complex Future – IBM Business Consulting Services whitepaper) have shown that supply chain operations can cost over one third of revenues and require about fifty per cent of total head count. Furthermore, one of the main reasons for drugs not launching on time is the readiness of the supply chain.

To keep pace with such a competitive and challenging market, pharmaceutical companies can no longer afford to carry the inefficiencies that have too often characterised the manufacturing supply chain. New and innovative ways of streamlining operations and improving control over process efficiency are required to ensure a more accurate and responsive supply chain.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Greg Tanner, Managing Director of Vocollect Europe, joined the company to expand its presence throughout Europe, the Middle East and Africa. He has a long career in international business development at the General Manager level, with experience in both direct and indirect sales organisations. Previously, Greg was Director of Channel Sales for Datalogic SpA, the European leader in barcode scanners and portable computers. As Managing Director for Zebra Technologies, the barcode printer manufacturer, he established Zebra Technologies Europe and opened the company’s first European facility in 1991. Greg is also a Member of the Board of AIM UK, the Trade Association for the Auto-ID industry.
spacer
Greg Tanner
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical, a biotechnology company, announce a strategic partnership. Under the terms of the collaboration, WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production, providing integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services from API to drug product.
More info >>

White Papers

The Rare Disease Patients Experience

When planning a clinical trial for a rare disease, it is important to have a holistic understanding of your patient population. You want to be aware of where your patients are coming from, and what it is like to walk in their shoes. These patients need your trial just as much as you need them; even from the earliest stages, conceptualize your rare disease trial as an altruistic relationship between the patient population and your study.
More info >>

 
Industry Events

SMi Presents the 4th Annual: Highly Potent Active Pharmaceutical Ingredients (HPAPI)

11-13 May 2020, Copthorne Tara Hotel, London, UK

SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 11th – 12th May 2020. HPAPI 2020 conference focuses on the growing landscape driven by the demand for highly potent drugs in oncology, diabetes and autoimmune disease treatment. This event will address the biggest challenges the industry is facing with regards to determining toxicology limits, assessing hazards, implementing risk procures, translating risk assessment into facility engineering, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement